Analysts: Avanir Pharmaceuticals Inc (AVNR.OQ)

AVNR.OQ on NASDAQ Stock Exchange Global Select Market

4.83USD
1:35pm EDT
Price Change (% chg)

$0.07 (+1.47%)
Prev Close
$4.76
Open
$4.74
Day's High
$4.93
Day's Low
$4.72
Volume
386,545
Avg. Vol
447,082
52-wk High
$5.09
52-wk Low
$2.07

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.09 September 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 4 4
(2) OUTPERFORM 4 4 2 2
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 1.75 1.57 1.57

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 8 22.08 24.10 19.62 22.80
Quarter Ending Dec-13 2 25.11 28.70 21.52 --
Year Ending Sep-13 8 76.41 78.80 71.59 75.60
Year Ending Sep-14 8 122.41 149.65 103.20 136.44
Earnings (per share)
Quarter Ending Sep-13 8 -0.09 -0.03 -0.16 -0.01
Quarter Ending Dec-13 2 -0.04 0.00 -0.08 --
Year Ending Sep-13 8 -0.40 -0.28 -0.60 -0.31
Year Ending Sep-14 8 -0.17 0.09 -0.38 -0.06

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 17.40 17.43 0.03 0.19
Quarter Ending Dec-12 16.42 16.52 0.10 0.59
Quarter Ending Sep-12 12.90 13.53 0.63 4.91
Quarter Ending Jun-12 10.35 10.05 0.30 2.93
Quarter Ending Mar-12 7.81 10.04 2.23 28.58
Earnings (per share)
Quarter Ending Mar-13 -0.09 -0.12 0.03 -37.77
Quarter Ending Dec-12 -0.08 -0.09 0.01 -10.16
Quarter Ending Sep-12 -0.09 -0.09 0.01 -5.88
Quarter Ending Jun-12 -0.11 -0.11 0.00 -3.09
Quarter Ending Mar-12 -0.12 -0.13 0.01 -5.43

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 22.08 22.08 21.68 21.59 22.80
Quarter Ending Dec-13 25.11 25.11 25.11 24.56 --
Year Ending Sep-13 76.41 76.41 75.89 75.85 75.60
Year Ending Sep-14 122.41 122.41 121.02 122.80 136.44
Earnings (per share)
Quarter Ending Sep-13 -0.09 -0.09 -0.07 -0.08 -0.01
Quarter Ending Dec-13 -0.04 -0.04 -0.04 -0.04 --
Quarter Ending Sep-13 -0.40 -0.40 -0.36 -0.37 -0.31
Quarter Ending Sep-14 -0.17 -0.17 -0.10 -0.09 -0.06

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 2 1
Quarter Ending Dec-13 0 0 0 0
Year Ending Sep-13 0 0 2 1
Year Ending Sep-14 0 0 2 0
Earnings
Quarter Ending Sep-13 0 0 1 5
Quarter Ending Dec-13 0 0 0 1
Year Ending Sep-13 0 0 1 4
Year Ending Sep-14 0 0 2 4

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks